Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A New Biomarker for the Non-invasive Diagnosis of Rejection After Heart Transplantation

NCT03477383 is registered in ClinicalTrials.gov with Vastra Gotaland Region as lead sponsor.

NCT NCT03477383
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03477383 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A New Biomarker for the Non-invasive Diagnosis of Rejection After Heart Transplantation
Lead sponsor
Vastra Gotaland Region
Phase
Observational
Overall status
Completed
Start date
March 1, 2016
Completion date
December 31, 2021
Enrollment
134 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

heart transplant rejection